Pfizer concealed that arthritis medicine could prevent Alzheimer’s
Pfizer’s Enbrel is the pharmacological star of the day. Not only is it a successful drug for rheumatoid arthritis, but it could reduce the risk of Alzheimer’s by 64 percent. A fact that, as The Washington Post reveals, the pharmaceutical company itself has been hiding for several years. It was in 2015 when, following an […]
Continue Reading